A Service of the National Health Information Center, U.S. Department of Health & Human Services
healthfinder® home page
        Help | Advanced Search
 News Library Just For You Health Care Organizations en Español
Health & Human Services Home Page

Home > News


Tablet-Splitting Saves VA Millions

  • E-mail this article
  • Subscribe to news
  • WEDNESDAY, Nov. 10 (HealthDayNews) -- The Department of Veterans Affairs health system saved $46.5 million in 2003 by having eligible patients split tablets of the cholesterol-lowering drug simvastatin in half, a new report says.

    The report said many drugs are available in higher-dose tablets that are the same price as lower-dose tablets. By splitting higher-dose tablets in half, patients can get their required dose for about half the cost and provide large savings for health systems that provide pharmacy benefits for patients.

    In 2003, 86 percent of eligible simvastatin (Zocor) prescriptions in VA systems nationwide were split in half, which resulted in savings of $46.5 million, the report said.

    It noted that tablet-splitting doesn't work with all pills, such as time-release tablets or pills with special coatings. And certain medical conditions, such as visual impairment or disabling arthritis, make it impossible for some patients to use tablet splitters.

    Statins are good choices for tablet-splitting because the dose doesn't have to be as exact as some other kinds of drugs to be effective, the report said.

    Patients should split tablets only with the approval of their doctor.

    The report was presented Wednesday at the American Heart Association's scientific sessions in New Orleans.

    More information

    The U.S. Food and Drug Administration has information about medicine safety.

    (SOURCE: U.S. Department of Veterans Affairs, news release, Nov. 10, 2004)

    Copyright © 2004 ScoutNews LLC. All rights reserved.

    HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder® does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder® health library.
    About Us  Accessibility  Disclaimer  Freedom of Information Act  Privacy  Contact Us
    Office of Disease Prevention and Health Promotion, U.S. Department of Health & Human Services